AU2003271548A1 - Use of skca channel blocking drugs for combating parkinson's disease - Google Patents
Use of skca channel blocking drugs for combating parkinson's diseaseInfo
- Publication number
- AU2003271548A1 AU2003271548A1 AU2003271548A AU2003271548A AU2003271548A1 AU 2003271548 A1 AU2003271548 A1 AU 2003271548A1 AU 2003271548 A AU2003271548 A AU 2003271548A AU 2003271548 A AU2003271548 A AU 2003271548A AU 2003271548 A1 AU2003271548 A1 AU 2003271548A1
- Authority
- AU
- Australia
- Prior art keywords
- disease
- channel blocking
- blocking drugs
- combating
- parkinson
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4748—Quinolines; Isoquinolines forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200201552 | 2002-10-13 | ||
DKPA200201552 | 2002-10-13 | ||
PCT/DK2003/000678 WO2004035056A1 (en) | 2002-10-13 | 2003-10-09 | Use of skca channel blocking drugs for combating parkinson's disease |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003271548A1 true AU2003271548A1 (en) | 2004-05-04 |
Family
ID=32103844
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003271548A Abandoned AU2003271548A1 (en) | 2002-10-13 | 2003-10-09 | Use of skca channel blocking drugs for combating parkinson's disease |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003271548A1 (en) |
WO (1) | WO2004035056A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003094861A2 (en) | 2002-05-13 | 2003-11-20 | Icagen, Inc. | Bis-benzimidazoles and related compounds as potassium channel modulators |
CA2575882A1 (en) * | 2004-08-05 | 2006-02-09 | Neurosearch A/S | 2-amino benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels |
TWI387592B (en) | 2005-08-30 | 2013-03-01 | Novartis Ag | Substituted benzimidazoles and methods of their use as inhibitors of kinases associated with tumorigenesis |
WO2010015037A1 (en) * | 2008-08-08 | 2010-02-11 | Howard Florey Institute | Therapeutic methods and compositions |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2044853C (en) * | 1990-07-19 | 2004-11-09 | Susan A. Greenfield | Method for treating parkinson's disease employing an atp-sensitive potassium channel blocker |
DK154092D0 (en) * | 1992-12-23 | 1992-12-23 | Neurosearch As | IMIDAZOLE COMPOUNDS, THEIR PREPARATION AND USE |
GB9612829D0 (en) * | 1996-06-19 | 1996-08-21 | Univ London | Potassium channel blockers |
US5874438A (en) * | 1996-10-11 | 1999-02-23 | Bayer Aktiengesellschaft | 2,2'-bridged bis-2,4-diaminoquinazolines |
US5760230A (en) * | 1996-10-11 | 1998-06-02 | Bayer Aktiengesellschaft | 4, 4'-bridged bis-2, 4-diaminoquinazolines |
US5739127A (en) * | 1996-11-08 | 1998-04-14 | Bayer Aktiengesellschaft | 2,4'-bridged bis-2,4-diaminoquinazolines |
AU5390900A (en) * | 1999-06-29 | 2001-01-22 | Neurosearch A/S | Potassium channel blocking agents |
EP1465609A2 (en) * | 2001-11-07 | 2004-10-13 | Medical Research Council | Modulation of dopaminergic neurons |
US7205307B2 (en) * | 2002-02-14 | 2007-04-17 | Icagen, Inc. | Pyrimidines as novel openers of potassium ion channels |
-
2003
- 2003-10-09 AU AU2003271548A patent/AU2003271548A1/en not_active Abandoned
- 2003-10-09 WO PCT/DK2003/000678 patent/WO2004035056A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2004035056A1 (en) | 2004-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003214191A1 (en) | Implantable medical device stream processor | |
AU2002334579A1 (en) | Medical device containing light-protected therapeutic agent | |
AU2003297621A1 (en) | Medical devices for delivery of therapeutic agents | |
AU2003291992A1 (en) | Phenylethanolamine derivatives for the treatment of respiratory diseases | |
AU2003272590A1 (en) | Method for ophtalmic administration of medicament | |
AU2003295614A1 (en) | Delivery of pharmaceutical agents via the human insulin receptor | |
AU2003279338A1 (en) | Phenethanolamine derivatives for the treatment of respiratory diseases | |
AU2002342050A1 (en) | Anesthesia drug monitor | |
AU2003223005A1 (en) | Application device for topical administration of pharmaceutical agents | |
AU2003234929A1 (en) | Therapeutic agent for diabetes | |
AU2003279442A1 (en) | 2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes | |
AU2002226690A1 (en) | Drugs for the diagnosis of tissue-reproductive activity or the treatment of proliferative diseases | |
AU2003243439A1 (en) | Medical device for intra-lumenal delivery of pharmaceutical agents | |
AU2001263383A1 (en) | Use of pyridinylimidazole carbamate derivate for the manufacture of a medicament for the treatment of cancer | |
EP1583506A3 (en) | Eye-drop vaccine containing copolymer 1 for therapeutic immunization | |
AU2003254146A1 (en) | Methods for the treatment of parkinson's disease | |
AU2003251904A1 (en) | Combinations of drugs for the treatment of neoplasms | |
AU5729099A (en) | Use of cyclopentabenzofuran-derivatives for combating nf-KappaB-dependent diseases | |
AU2003250317A1 (en) | Device for administration of fluids | |
AU2003271548A1 (en) | Use of skca channel blocking drugs for combating parkinson's disease | |
AU2003228464A1 (en) | Apparatus for treatment of meniere's disease | |
AU2002322263A1 (en) | Eglin c based drugs for treatment of disease | |
AU2002251541A1 (en) | Apparatus and assembly for administering antimicrobial agent | |
AU2003209542A1 (en) | Use of s-substituted l-crysteine for the manufacture of a medicament for the treatment of dermatological disorders | |
AU2003247001A1 (en) | Processes for the preparation of oral dosage formulations of modafinil |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |